title: Red urinary discolouration following hydroxocobalamin treatment for vasoplegic syndrome.
authors.affiliation: Division of Critical Care Medicine, Mayo Clinic, Rochester, MN, USA. warner.matthew@mayo.edu.|Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA. warner.matthew@mayo.edu.
authors.forename: Matthew A
authors.identifier: 0000-0002-6625-8755
authors.initials: MA
authors.lastname: Warner
authors.affiliation: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.|Division of Adult Cardiothoracic Anesthesiology, Mayo Clinic, Rochester, MN, USA.
authors.forename: William J
authors.initials: WJ
authors.lastname: Mauermann
authors.affiliation: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.|Division of Adult Cardiothoracic Anesthesiology, Mayo Clinic, Rochester, MN, USA.
authors.forename: Sarah
authors.initials: S
authors.lastname: Armour
authors.affiliation: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.|Division of Adult Cardiothoracic Anesthesiology, Mayo Clinic, Rochester, MN, USA.
authors.forename: David W
authors.initials: DW
authors.lastname: Barbara
mesh_terms: D000369:Aged, 80 and over; D003116:Color; D006801:Humans; D006879:Hydroxocobalamin / Q000008:administration & dosage*; D008297:Male; D014556:Urine / Q000737:chemistry*; D056987:Vasoplegia / Q000188:drug therapy*; D014803:Vitamin B Complex / Q000008:administration & dosage*
chemical_list: D014803:Vitamin B Complex; D006879:Hydroxocobalamin